Skip to main content
VCbacked
Log inGet Started

Madrigal Pharmaceuticals

Conshohocken, United States

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

$350.0M raised
Jul 2025
Post-IPO Debt
BiopharmaBiotechnologyMedical DevicePharmaceutical

Top Investors

Blue OwlHercules CapitalBay City Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Madrigal Pharmaceuticals

How much funding has Madrigal Pharmaceuticals raised?
Madrigal Pharmaceuticals has raised $350.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in July 2025.
Who are Madrigal Pharmaceuticals's investors?
Madrigal Pharmaceuticals's investors include Blue Owl, Hercules Capital, Bay City Capital.
Where is Madrigal Pharmaceuticals headquartered?
Madrigal Pharmaceuticals is headquartered in Conshohocken, United States.
What does Madrigal Pharmaceuticals do?
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
What stage is Madrigal Pharmaceuticals at?
Madrigal Pharmaceuticals is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Madrigal Pharmaceuticals — Funding & Investors." VCBacked, July 22, 2025, https://www.vcbacked.co/company/madrigal-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2025). Madrigal Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/madrigal-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Madrigal Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/madrigal-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M